跳至主要内容
临床试验/NCT02413242
NCT02413242已完成不适用

Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU

Jan Kluytmans1 个研究点 分布在 1 个国家目标入组 2,031 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,031
试验地点
1
主要终点
Incidence of P. aeruginosa ICU pneumonia

研究概览

简要总结

Intensive Care Unit (ICU) acquired pneumonia, including ventilator-associated pneumonia, is a frequently occurring health-care associated infection, which causes considerable morbidity, mortality and health care costs. Important pathogens causing ICU pneumonia are Staphylococcus aureus and Pseudomonas aeruginosa. The epidemiology of ICU pneumonia and patient-related and contextual factors is not fully described, but is urgently needed to support the development of effective interventions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant is 18 years or older at the time of enrollment.
  • Participant is on mechanical ventilation at ICU admission, or is (expected to be) within 24 hours thereafter, based on investigator's judgment.
  • Expected stay in ICU is 48 hours or longer based on investigator's judgment.
  • SA colonization status is known within 72 hours after start of first episode of mechanical ventilation and according to the result, the patient qualifies for enrollment.
  • Written informed consent from subject / legally accepted representative within 72 hours after start of first episode of mechanical ventilation.

排除标准

  • Previous participation as a subject in the study cohort of this study.
  • Simultaneous participation of the subject in any preventive experimental study into anti-staphylococcus or anti-pseudomonas aeruginosa interventions.
  • Expected death (moribund status) within 48h, or ICU discharge of the participant within 24h, at the moment of informed consent.

结局指标

主要结局

Incidence of P. aeruginosa ICU pneumonia

时间窗: date of ICF until ICU discharge (on average 7 days after ICF)

Incidence of S. aureus ICU pneumonia

时间窗: date of ICF until ICU discharge (on average 7 days after ICF)

次要结局

  • Incidence of P. aeruginosa ICU pneumonia stratified by MDR-PA vs. S-PA(date of ICF until ICU discharge (on average 7 days after ICF))
  • Time to all cause ICU pneumonia(day of ICU admission until ICU discharge (on average 7 days after ICU admission))
  • Incidence of ICU bacteremia per etiologic agent (in case of S. aureus and/or P. aeruginosa and for all clinically relevant other pathogens)(date of ICF until ICU discharge (on average 7 days after ICF))
  • Incidence of all cause ICU pneumonia(date of ICF until ICU discharge (on average 7 days after ICF))
  • Time to P. aeruginosa ICU pneumonia(day of ICU admission until ICU discharge (on average 7 days after ICU admission))
  • Prevalence of S. aureus / P. aeruginosa colonization(at ICU admission)
  • Incidence of S. aureus ICU pneumonia stratified by MRSA vs. MSSA(date of ICF until ICU discharge (on average 7 days after ICF))
  • All-cause mortality(At day 90 after ICU admission)
  • Time to S. aureus ICU pneumonia(day of ICU admission until ICU discharge (on average 7 days after ICU admission))
  • Time to all cause ICU bacteremia(day of ICU admission until ICU discharge (on average 7 days after ICU admission))
  • Time to death of any cause(day of ICU admission until day 90 or ICU discharge, whichever comes first)

研究者

发起方
Jan Kluytmans
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jan Kluytmans

Professor

UMC Utrecht

研究点 (1)

Loading locations...

相似试验